Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac eye drops vs bevacizumab vs triamcinolone to prevent retinal edema after cataract surgery in diabetic retinopathy
IRCT2017050833875N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of diclofenac, bevacizumab and triamcinolone in diabetic retinopathy (DR) and diabetic macular edema (DME) (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Prevention of retinal/macular edema. Started May 2017; status: completed.
02
Drugs
diclofenacbevacizumabtriamcinolone
03
Conditions
diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT2017050833875N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017050833875N1.